• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

headlines

gsgs

Registered User
Baltimore Sun Study: 50% of Americans want H1N1 vaccine

A study published by the New England Journal of Medicine has said that contributing factor for death in H1N1 patients in Mexico may have been delayed

UofIowa begins testing H1N1 vaccines

Nationwide, 800 people will be enrolled in the H1N1 study. There's no shortage of volunteers

Seasonal Flu Shot Doesn't Protect Against Swine Flu, Study Says

Novavax achieves milestone in novel H1N1 influenza vaccine technology

Glaxo to produce 300M doses until fall in Dresden
 
Re: headlines

translation:

Thousands - (Feature) With chicken eggs against swine flu
in Dresden from GlaxoSmithKline will work until the autumn of 300 million
doses produced - From Reuters correspondent Henry Berndt -
(With images and data sheet) 15.08.2009 | 11:06 Uhr 15.08.2009 | 11:06 clock
Pandemrix.
The vaccine against the swine flu was not yet officially tested or approved.
To get to a feared flu wave in the autumn ready enough doses to have the production
in Dresden, however, since the end of June in full swing.
As Anke Helter company spokeswoman says that in these coming days 380 000 eggs daily
into the production.
They get pathogens inoculated which the WHO in May to 20 worldwide sent to
pharmaceutical manufacturer. Within a 18-day process, finally won the antigens.
According to GSK's CEO, Peter Schu by this way until the autumn of up to 300 million
doses for Germany, Europe and parts of Asia will be produced.
The federal German government already has 50 million doses ordered in Dresden.
Parallel to the production run at several universities, the studies on the effectiveness of,
for example, in Würzburg and Regensburg.
Volunteers can be there in an interval of 14 days, two doses of vaccination, just as soon
large parts of the German population could do.
...
Instead of filling ampoules already, cooks GSK is currently "a giant soup pot virus",
as it vividly Anke Helter formulated.
Expected in September Pandemrix will come onto the market.
"We currently have authorization to stay ahead," Helter says, "because we already
have an approved vaccine against the H5N1 bird flu had developed."
The competition from Novartis of Switzerland is moving to a different production system
and would like from the fourth quarter of 2009 to deliver .
To proceed with the orders at GSK in Dresden until the autumn all the resources exclusively
for the production of swine flu vaccine used. The normal seasonal vaccine, according to
spokeswoman Helter «fortunately almost finished."
Total of 150 additional employees, the company looking for long-term use against the pandemic.
Only about half of the jobs had yet been filled.
...

searching for the adjuvans-article now...

see here for google-tanslation:

http://translate.google.com/transla...k-impfstoff-gegen-r1433133.htm&hl=en&ie=UTF-8
 
Back
Top